Royalderm Agnieszka Nawrocka

Warsaw 5 trials

5 Registered trials

0 Currently recruiting

Organisation

Royalderm Agnieszka Nawrocka

Location

Warsaw, Poland

Identifier

ORG-100045574

Address

Ul. Krzysztofa Kieslowskiego 3b/3, 02-962, Poland

Departments

Dermatology
Private practice
Royalderm Agnieszka Nawrocka

Clinical trials at this site (5)

Search interface

A study to test whether spesolimab helps people with a skin disease called hidradenitis suppurativa Ended

2022-501074-19-00 Hidradenitis suppurativa 10 2023-10-13
A Phase 3 Study Investigating the Efficacy, Safety, and Tolerability of Ritlecitinib in Participants with Nonsegmental Vitiligo Ended

2022-501668-16-00 NON SEGMENTAL VITILIGO 5 2023-06-26
A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa (S… Ended

2022-501753-36-00 Hidradenitis Suppurativa 5 2023-06-02
Phase 3, 52-week Study Evaluating Rocatinlimab (AMG451)in Adolescent Subjects With Moderate-to-severe AD (ROCKET-ASTRO) Ended

2022-501586-50-00 Atopic Dermatitis 5 2023-05-15
A Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab Monotherapy in Moderate-to-severe AD (ROCKET-Ignite) Ended

2022-501540-15-00 Atopic Dermatitis 5 2023-04-25